Effects of combined valproic acid and the epidermal growth factor/vascular endothelial growth factor receptor tyrosine kinase inhibitor AEE788 on renal cell carcinoma cell linesin vitro

BJU International ◽

10.1111/j.1464-410x.2009.08759.x ◽

2010 ◽

Vol 105 (4) ◽

pp. 549-557 ◽

Author(s):

Eva Juengel ◽

Johanna Engler ◽

Ausra Mickuckyte ◽

Jon Jones ◽

Lukasz Hudak ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Growth Factor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Carcinoma Cell ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Renal Cell Carcinoma Cell ◽

Epidermal Growth ◽

Endothelial Growth Factor

Download Full-text

Everolimus in Patients with Metastatic Renal Cell Carcinoma Who Progress after Initial Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitor (VEGFR-TKI) Therapy: UK Results from the react Trial on Behalf of the UK React Investigators

Annals of Oncology ◽

10.1016/s0923-7534(20)33390-1 ◽

2012 ◽

Vol 23 ◽

pp. ix271-ix272

Author(s):

S. Chowdhury ◽

J. Larkin

Keyword(s):

Renal Cell Carcinoma ◽

Vascular Endothelial Growth Factor ◽

Growth Factor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

The Uk ◽

Endothelial Growth Factor

Download Full-text

Abstract 3681: Vascular endothelial growth factor receptor tyrosine kinase inhibitor inhibited mutated epidermal growth factor receptor-driven tumors ex vivo and in vivo

10.1158/1538-7445.am2011-3681 ◽

2011 ◽

Author(s):

Toshio Kubo ◽

Kadoaki Ohashi ◽

Masahiro Osawa ◽

Hiromasa Takeda ◽

Eiki Ichihara ◽

...

Keyword(s):

Vascular Endothelial Growth Factor ◽

Growth Factor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Ex Vivo ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Epidermal Growth ◽

Endothelial Growth Factor

Download Full-text

Everolimus in metastatic renal cell carcinoma: Subgroup analysis of patients with 1 or 2 previous vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapies enrolled in the phase III RECORD-1 study

European Journal of Cancer ◽

10.1016/j.ejca.2011.11.027 ◽

2012 ◽

Vol 48 (3) ◽

pp. 333-339 ◽

Author(s):

E. Calvo ◽

B. Escudier ◽

R.J. Motzer ◽

S. Oudard ◽

T.E. Hutson ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Vascular Endothelial Growth Factor ◽

Growth Factor ◽

Receptor Tyrosine Kinase ◽

Subgroup Analysis ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Phase Iii ◽

Vascular Endothelial ◽

Endothelial Growth Factor

Download Full-text

Editorial Comment to Activity of axitinib in patients with metastatic renal cell carcinoma previously treated with both vascular endothelial growth factor receptor tyrosine-kinase inhibitor and mammalian target of rapamycin inhibitor

International Journal of Urology ◽

10.1111/iju.12423 ◽

2014 ◽

Vol 21 (7) ◽

pp. 741-741

Author(s):

Yoshihiro Wada

Keyword(s):

Renal Cell Carcinoma ◽

Vascular Endothelial Growth Factor ◽

Growth Factor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Mammalian Target Of Rapamycin ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Previously Treated ◽

Endothelial Growth Factor

Download Full-text

Vascular endothelial growth factor receptor tyrosine kinase inhibitor (VEGFR-TKI) rechallenge for patients with metastatic renal cell carcinoma after treatment failure using both VEGFR-TKI and mTOR inhibitor

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-015-2725-8 ◽

2015 ◽

Vol 75 (5) ◽

pp. 1025-1035 ◽

Author(s):

Inkeun Park ◽

Jae-Lyun Lee ◽

Jin-Hee Ahn ◽

Dae-Ho Lee ◽

Kyoo-Hyung Lee ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Vascular Endothelial Growth Factor ◽

Growth Factor ◽

Treatment Failure ◽

Receptor Tyrosine Kinase ◽

Mtor Inhibitor ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Endothelial Growth Factor

Download Full-text

Stereotactic Radiotherapy for the Treatment of Patients With Oligo-progressive Metastatic Renal Cell Carcinoma Receiving Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor: Data From the Real World

Anticancer Research ◽

10.21873/anticanres.14730 ◽

2020 ◽

Vol 40 (12) ◽

pp. 7037-7043

Author(s):

VITTORIO GEBBIA ◽

ANDREA GIRLANDO ◽

ALFIO DI GRAZIA ◽

IVAN FAZIO ◽

NICOLÒ BORSELLINO ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Vascular Endothelial Growth Factor ◽

Growth Factor ◽

Receptor Tyrosine Kinase ◽

Stereotactic Radiotherapy ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Endothelial Growth Factor

Download Full-text

A Multicenter Phase II Trial of ZD6474, a Vascular Endothelial Growth Factor Receptor-2 and Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients with Previously Treated Metastatic Breast Cancer

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-04-1923 ◽

2005 ◽

Vol 11 (9) ◽

pp. 3369-3376 ◽

Author(s):

Kathy D. Miller ◽

Jose Manuel Trigo ◽

Catherine Wheeler ◽

Alan Barge ◽

Jacqui Rowbottom ◽

...

Keyword(s):

Growth Factor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Metastatic Breast ◽

Vascular Endothelial ◽

Multicenter Phase ◽

Previously Treated ◽

Epidermal Growth ◽

Endothelial Growth Factor

Download Full-text

A Multicenter Phase II Trial of ZD6474, a Vascular Endothelial Growth Factor Receptor-2 and Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Previously Treated Metastatic Breast Cancer

Breast Diseases A Year Book Quarterly ◽

10.1016/s1043-321x(05)80307-8 ◽

2006 ◽

Vol 16 (4) ◽

pp. 375

Author(s):

M.N. Dickler

Keyword(s):

Growth Factor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Metastatic Breast ◽

Vascular Endothelial ◽

Multicenter Phase ◽

Previously Treated ◽

Epidermal Growth ◽

Endothelial Growth Factor

Download Full-text

Final results of the international, expanded-access program of everolimus in patients with advanced renal cell carcinoma who progress after prior vascular endothelial growth factor receptor–tyrosine kinase inhibitor (VEGFr-TKI) therapy.

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.4601 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. 4601-4601

Author(s):

V. Grünwald ◽

P. I. Karakiewicz ◽

S. E. Bavbek ◽

K. Miller ◽

J. H. Machiels ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Vascular Endothelial Growth Factor ◽

Growth Factor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Expanded Access Program ◽

Endothelial Growth Factor ◽

Download Full-text

A specific vascular endothelial growth factor receptor tyrosine kinase inhibitor enhances the antiproliferative effect of trastuzumab in human epidermal growth factor receptor 2 overexpressing breast cancer cell lines

The American Journal of Surgery ◽

10.1016/j.amjsurg.2008.10.009 ◽

2009 ◽

Vol 197 (3) ◽

pp. 331-336 ◽

Author(s):

Elizabeth M.H. Kim ◽

Catherine Lobocki ◽

Linda Dubay ◽

Vijay K. Mittal

Keyword(s):

Breast Cancer ◽

Vascular Endothelial Growth Factor ◽

Growth Factor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Breast Cancer Cell Lines ◽

Vascular Endothelial ◽

Epidermal Growth ◽

Endothelial Growth Factor

Download Full-text